Medtronic rises on better-than-expected 4Q results
Medtronic shares rose 5 percent Tuesday after the company reported better-than-expected fourth quarter earnings on sales of implantable heart defibrillators and pacemakers. Full story
Medtronic shares rose 5 percent Tuesday after the company reported better-than-expected fourth quarter earnings on sales of implantable heart defibrillators and pacemakers. Full story
New research is challenging medical guidelines that say people with a heart-zapping device in their chests should avoid intense sports like basketball and soccer in favor of golf or bowling. Full story
Medtronic has put two new implantable heart devices on the market after receiving approval from federal regulators. Full story
Medical device maker Boston Scientific Corp. said Thursday it swung to a first-quarter loss on restructuring charges and a write-down of the value of its defibrillator business. Full story
The FDA is setting setting new rules for defibrillators: Those portable machines that deliver an electric shock to the heart: they can mean the difference between life and death when someone is having a heart attack. NBC’s Robert Bazell reports.
(Reuters) - The U.S. Food and Drug Administration is proposing new rules aimed at improving the reliability of emergency defibrillators following some 45,000 reports of device failures over the past seven years. Full story
